{"database": "lobbying", "table": "lobbying_activities", "rows": [[3186413, "aa04074b-44b0-484c-824f-c72343cc5ef2", "Q2", "INLET STRATEGIES", 401106604, "COHERUS BIOSCIENCES, INC", 2024, "second_quarter", "MMM", "Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office", 45000, null, 0, 0, "2024-07-06T19:49:18-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3186413"], "units": {}, "query_ms": 34.80905492324382, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}